Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of India. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Indian pharmaceutical market was valued at $19.8B in 2010 and increased to $27.6B in 2016 at a Compound Annual Growth Rate (CAGR) of 5.6%. Its value was forecast to be $30.8B in 2018 and expected to reach $38.3B by 2022. The medical devices industry was valued at $18.9B in 2018 and is forecast to increase to $25.4B in 2022. India offers affordable medical services which has resulted in a rise in the country’s medical tourism market. In 2016, 427,014 medical visas were issued by India. This was 4.85% of the total visas issued by India that year. India has also emerged as a hub for R&D activities for international players due to its cost-effective clinical research.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the India, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Sun Pharma, Biocon, Lupin, Cipla and Zydus Cadila) and profiles and SWOT analyses of the major players in the medical device market (Roche Diagnostics, DePuy Synthes, Abbott and Allengers)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of India
  • Porter’s five forces analysis for pharmaceutical and medical devices market of India
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Indian healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Indian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Indian healthcare market.


Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Top Five Therapeutic Areas by Annual Turnover ($B), India, 2017
Table 2: Medical Device Market, India, Revenue by Segment ($B) and Share (%), 2017
Table 3: Ophthalmic Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 4: Cardiovascular Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 5: IVD Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 6: Diagnostic Imaging Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 7: Orthopedic Devices Market, India, Revenue ($M) and Market Share (%) of Major Companies, 2017
Table 8: Conditionalities and Installments under PMMVY, India, 2017
Table 9: Insurance Penetration (%), India, 2016-2017
Table 10: Major Public Insurance Schemes, India, 2017
Table 11: Fees for the Approval of New Drugs, 2018, India
Table 12: Legal Provisions for Permission to Import/Manufacture New Drugs, 2018, India
Table 13: Fees for Clinical Trial/Approval of New Drugs, 2018, India
Table 14: Patent Fees, 2018, India
Table 15: Schedule of Trademark Fees, 2018, India
List of Figures
Figure 1: Pharmaceutical Market, India, Revenue ($B), 2010-2018
Figure 2: Medical Device Market, India, Revenue ($B), 2015-2022
Figure 3: Country Profile, India, 2017
Figure 4: Pharmaceutical Market, India, Revenue ($B), 2010-2017
Figure 5: Pharmaceutical Market, India, Revenue Forecast ($B), 2018-2022
Figure 6: Pharmaceutical Exports ($B), India, 2010-2017
Figure 7: Top Export Partners, India, 2017
Figure 8: Pharmaceutical Imports ($B), India, 2010-2017
Figure 9: Top Import Partners, India, 2017
Figure 10:Pharmaceutical Value Chain, India, 2016
Figure 11: Biocon Biosimilar Partners, India, 2017-2018
Figure 12: Pharmaceutical Trade Balance ($M), India-China, 2013-2017
Figure 13: Medical Visas (Number), India, 2013-2015
Figure 14: Guidelines for the Promotion of Wellness and Medical Tourism, India, 2016
Figure 15: Top Five Therapeutic Areas by Annual Turnover ($B), India, 2017
Figure 16: Medical Device Market, India, Revenue ($B), 2015-2020
Figure 17: Medical Device Market, India, Revenue Forecast ($B), 2021-2025
Figure 18: Medical Device Market, India, Revenue by Segment ($B), 2017
Figure 19: Ophthalmic Devices Market, India, Revenue ($B), 2015-2022
Figure 20: Ophthalmic Devices Market, India, Market Share of Major Players (%), 2015
Figure 21: Cardiovascular Devices Market, India, Revenue ($B), 2015-2022
Figure 22: Cardiovascular Devices Market, India, Market Share of Major Players (%), 2017
Figure 23: IVD Devices Market, India, Revenue ($bn), 2015-2022
Figure 24: IVD Devices Market, India, Market Share of Major Players (%), 2017
Figure 25: Diagnostic Imaging Market, India, Revenue ($B), 2015-2022
Figure 26: Diagnostic Imaging Market, India, Market Share of Major Players (%), 2015
Figure 27: Orthopedic Devices Market, India, Revenue ($B), 2015-2022
Figure 28: Orthopedic Devices Market, India, Market Share of Major Companies (%), 2017
Figure 29: Diagnostic Market, India, Revenue ($B), 2015-2020
Figure 30: Diagnostic Market, India, Revenue ($B), 2021-2025
Figure 31: Medical Devices Market, India, Revenue ($B) of Major Companies, 2017
Figure 32: Deal Value and Deal Count, Pharmaceutical Market, India, 2017-2018
Figure 33: Deal Value and Deal Count Quarterly, Pharmaceutical Market, India, 2017-2018
Figure 34: Deal Value and Deal Count Sub-types, Pharmaceutical Market, India, 2017-2018
Figure 35: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, India, 2017-2018
Figure 36: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, India, 2017-2018
Figure 37: M&A Deals by Therapy Area, Pharmaceutical Market, India, 2017-2018 (by value and by number)
Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market India, 2017-2018 (by value and by number)
Figure 39: Medical Device Market Deals, India, 2017-2018 (by deal value, $M)
Figure 40: Medical Device Market Deals, India, 2017-2018 (by deal Count)
Figure 41: Medical Device Market deals share (by deal count), India, 2017-2018
Figure 42: Medical Device Market deals share (by deal value), India, 2017-2018
Figure 43: Top Five Therapy Areas by Deal Value, Medical Device, India, 2017-2018
Figure 44: Top Five Therapy Areas by Deal Number, Medical Device, India, 2017-2018
Figure 45: M&A Deals by Therapy Area, Medical Device, India, 2017-2018 (by value and by number)
Figure 46: Venture Financing Deals by Therapy Area, Medical Device, India, 2017-2018 (by value and by number)
Figure 47:Private Equity Deals by Therapy Area, Medical Device India, 2017-2018 (by value and by number)
Figure 48: Key Regulatory Authorities and Responsibilities, India, 2018
Figure 49: Organization of Health System, India, 2018
Figure 50: OOP Expenditure Per Capita (% of health spending), India, 2010-2017
Figure 51: Annual Rate of Change (%), Health Price Index, India, 2010-2017
Figure 52: CDSCO, Organizational Structure, India, 2018
Figure 53: Outline of Evaluation Process by IND Committee/SECs for IND, India
Figure 54: Approval Process for Application Received in Hard Copy with Respect to Medical Devices
Figure 55: Approval Process for Application Received in the Online Sugam Portal with Respect to Medical Devices
Figure 56: Organizational Structure of the Controller General of Patents, Designs and Trade Marks, India, 2018
Figure 57: Patent Approval Process, India, 2018
Figure 58: Trademark Registration Process, India, 2018
Figure 59: Government Hospitals (Number), India, 2010-2018
Figure 60: Diagnostic Equipment (Number), India, 2015-2022
Figure 61: Hospital Beds (per 1,000 population), India, 2010 - 2017
Figure 62: Life Expectancy (years), India, 2010-2017
Figure 63: Immunization Rate (%), India, 2010-2017
Figure 64: Major Causes of Mortality, Deaths (%), India, 2012
Figure 65: Major Causes of Male Mortality, No. of Deaths (‘000), India, 2016
Figure 66: Major Causes of Female Mortality, No. of Deaths (‘000), India, 2016
Figure 67: Disability-Adjusted Life Years by Major Disease (‘000), India, 2016
Figure 68: Physicians (per 1,000 population), India, 2010-2017
Figure 69: Nurses (per 1,000 population), India , 2010-2017
Figure 70: Registered Dental Surgeons, India, 2010-2017
Figure 71: PM2.5 (μg per m3), India, 2010-2017
Figure 72: CO2 Emissions (k tons), India, 2010-2017
Figure 73: Healthcare Expenditure (% of GDP), India, 2009-2018
Figure 74: Public Health Expenditure (Center-State Share %), India, 2010-2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report